| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 7 | 2017 | 371 | 1.910 |
Why?
|
| Metal Nanoparticles | 5 | 2018 | 88 | 1.700 |
Why?
|
| Drug Delivery Systems | 7 | 2018 | 236 | 1.440 |
Why?
|
| Gold | 5 | 2018 | 76 | 1.380 |
Why?
|
| Drug Carriers | 4 | 2019 | 90 | 1.350 |
Why?
|
| Antineoplastic Agents | 7 | 2020 | 1070 | 1.340 |
Why?
|
| Optical Imaging | 3 | 2017 | 46 | 1.160 |
Why?
|
| Molecular Imaging | 3 | 2017 | 45 | 1.140 |
Why?
|
| Luminescent Measurements | 2 | 2017 | 58 | 1.130 |
Why?
|
| Receptors, Transferrin | 3 | 2015 | 18 | 1.100 |
Why?
|
| ErbB Receptors | 5 | 2015 | 239 | 1.090 |
Why?
|
| Theranostic Nanomedicine | 2 | 2015 | 6 | 1.020 |
Why?
|
| Fluorescent Dyes | 4 | 2019 | 191 | 0.860 |
Why?
|
| Glioblastoma | 2 | 2016 | 219 | 0.860 |
Why?
|
| beta-Galactosidase | 2 | 2015 | 88 | 0.850 |
Why?
|
| Nanoparticles | 5 | 2019 | 254 | 0.840 |
Why?
|
| Glioma | 5 | 2017 | 140 | 0.820 |
Why?
|
| Photochemotherapy | 4 | 2015 | 59 | 0.800 |
Why?
|
| Mice, Nude | 8 | 2019 | 294 | 0.730 |
Why?
|
| Alkylating Agents | 1 | 2019 | 15 | 0.680 |
Why?
|
| Salicylates | 1 | 2019 | 22 | 0.680 |
Why?
|
| Pyrenes | 1 | 2019 | 15 | 0.680 |
Why?
|
| Cell Line, Tumor | 12 | 2020 | 1851 | 0.660 |
Why?
|
| Photosensitizing Agents | 3 | 2015 | 32 | 0.650 |
Why?
|
| Neoplasms | 3 | 2018 | 1667 | 0.610 |
Why?
|
| Nanomedicine | 1 | 2018 | 19 | 0.610 |
Why?
|
| Keratinocytes | 9 | 2005 | 68 | 0.600 |
Why?
|
| Luminescent Agents | 1 | 2017 | 11 | 0.580 |
Why?
|
| Brain Stem Neoplasms | 1 | 2017 | 6 | 0.570 |
Why?
|
| Pons | 1 | 2017 | 35 | 0.560 |
Why?
|
| Delayed-Action Preparations | 2 | 2016 | 120 | 0.550 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2016 | 10 | 0.540 |
Why?
|
| Dacarbazine | 1 | 2016 | 32 | 0.540 |
Why?
|
| Animals | 25 | 2021 | 20881 | 0.530 |
Why?
|
| Nanotechnology | 1 | 2017 | 109 | 0.530 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2016 | 57 | 0.530 |
Why?
|
| S100 Proteins | 4 | 2004 | 42 | 0.520 |
Why?
|
| Indoles | 2 | 2015 | 146 | 0.500 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 307 | 0.470 |
Why?
|
| Epidermis | 5 | 2005 | 42 | 0.410 |
Why?
|
| Mice | 15 | 2021 | 8474 | 0.380 |
Why?
|
| Genes, Reporter | 4 | 2017 | 191 | 0.370 |
Why?
|
| Epidermal Growth Factor | 3 | 2017 | 95 | 0.360 |
Why?
|
| Isoflavones | 2 | 2020 | 31 | 0.340 |
Why?
|
| Streptavidin | 2 | 2017 | 10 | 0.270 |
Why?
|
| Biotinylation | 2 | 2017 | 27 | 0.270 |
Why?
|
| Brain | 2 | 2018 | 2176 | 0.270 |
Why?
|
| Humans | 29 | 2021 | 68618 | 0.270 |
Why?
|
| Blood-Brain Barrier | 2 | 2018 | 99 | 0.270 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 508 | 0.270 |
Why?
|
| Oligopeptides | 2 | 2017 | 152 | 0.260 |
Why?
|
| Gene Expression | 3 | 2017 | 770 | 0.230 |
Why?
|
| Transfection | 4 | 2017 | 782 | 0.230 |
Why?
|
| Microtubules | 1 | 2004 | 104 | 0.220 |
Why?
|
| Annexin A2 | 1 | 2003 | 3 | 0.220 |
Why?
|
| Psoriasis | 1 | 2003 | 46 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 304 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 46 | 0.180 |
Why?
|
| Voltage-Dependent Anion Channel 2 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Peptide Fragments | 2 | 2015 | 483 | 0.180 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2020 | 10 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 689 | 0.180 |
Why?
|
| Adherens Junctions | 1 | 2020 | 13 | 0.180 |
Why?
|
| Transglutaminases | 3 | 2005 | 67 | 0.180 |
Why?
|
| Apoptosis | 5 | 2020 | 1641 | 0.180 |
Why?
|
| Ultrasonography | 2 | 2013 | 453 | 0.170 |
Why?
|
| Mustard Gas | 1 | 2019 | 1 | 0.170 |
Why?
|
| Pipobroman | 1 | 2019 | 1 | 0.170 |
Why?
|
| Busulfan | 1 | 2019 | 13 | 0.170 |
Why?
|
| Chemical Warfare Agents | 1 | 2019 | 4 | 0.170 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 23 | 0.170 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 40 | 0.170 |
Why?
|
| Colon | 1 | 2020 | 168 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 41 | 0.170 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2019 | 112 | 0.170 |
Why?
|
| RNA Interference | 1 | 2020 | 266 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 151 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 170 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 183 | 0.160 |
Why?
|
| Fever | 1 | 2018 | 96 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 852 | 0.150 |
Why?
|
| Liposomes | 1 | 2018 | 107 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 3 | 2015 | 261 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 332 | 0.150 |
Why?
|
| Luciferases, Firefly | 1 | 2017 | 5 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2020 | 431 | 0.150 |
Why?
|
| Cell Survival | 4 | 2015 | 901 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2020 | 447 | 0.150 |
Why?
|
| Doxorubicin | 1 | 2018 | 231 | 0.150 |
Why?
|
| Tumor Burden | 1 | 2017 | 132 | 0.140 |
Why?
|
| Phosphatidylethanolamines | 1 | 2016 | 20 | 0.140 |
Why?
|
| Micelles | 1 | 2016 | 43 | 0.130 |
Why?
|
| Sepsis | 1 | 2019 | 233 | 0.130 |
Why?
|
| Protons | 1 | 2016 | 57 | 0.130 |
Why?
|
| Histidine | 1 | 2015 | 17 | 0.130 |
Why?
|
| Biotin | 1 | 2015 | 28 | 0.130 |
Why?
|
| Mitral Valve Prolapse | 1 | 2015 | 40 | 0.130 |
Why?
|
| Stereotaxic Techniques | 1 | 2015 | 35 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.130 |
Why?
|
| Cadherins | 1 | 2015 | 93 | 0.120 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 160 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 54 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.120 |
Why?
|
| Plant Viruses | 1 | 2013 | 3 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2550 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 2 | 2003 | 114 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 118 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 250 | 0.110 |
Why?
|
| Optical Phenomena | 1 | 2012 | 5 | 0.110 |
Why?
|
| Contrast Media | 2 | 2013 | 595 | 0.100 |
Why?
|
| Cytoplasm | 2 | 2020 | 155 | 0.100 |
Why?
|
| Time Factors | 3 | 2017 | 4655 | 0.100 |
Why?
|
| Hernia, Abdominal | 1 | 2011 | 7 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2013 | 229 | 0.090 |
Why?
|
| Poloxamer | 1 | 2011 | 10 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 42 | 0.090 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 11 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 659 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1173 | 0.090 |
Why?
|
| Escherichia coli K12 | 1 | 2010 | 9 | 0.090 |
Why?
|
| Rats | 4 | 2011 | 5300 | 0.090 |
Why?
|
| Bioprosthesis | 1 | 2011 | 101 | 0.090 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 36 | 0.090 |
Why?
|
| Biofilms | 1 | 2010 | 72 | 0.090 |
Why?
|
| Mutation | 1 | 2015 | 1213 | 0.090 |
Why?
|
| Surgical Mesh | 1 | 2010 | 57 | 0.090 |
Why?
|
| Carcinogenesis | 2 | 2021 | 124 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 175 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1174 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.080 |
Why?
|
| Female | 8 | 2020 | 38074 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 475 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2004 | 2673 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 499 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2005 | 1034 | 0.070 |
Why?
|
| S100 Calcium Binding Protein A7 | 2 | 2003 | 4 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 150 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2003 | 525 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 561 | 0.060 |
Why?
|
| Brefeldin A | 1 | 2004 | 11 | 0.060 |
Why?
|
| Langerhans Cells | 1 | 2004 | 10 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 32 | 0.060 |
Why?
|
| Antibody Specificity | 1 | 2004 | 98 | 0.060 |
Why?
|
| Sesquiterpenes | 1 | 2004 | 41 | 0.060 |
Why?
|
| Carcinogens | 1 | 2004 | 86 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 138 | 0.060 |
Why?
|
| Tubulin | 1 | 2004 | 60 | 0.060 |
Why?
|
| Lactones | 1 | 2004 | 64 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 80 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2003 | 48 | 0.060 |
Why?
|
| Calgranulin B | 1 | 2003 | 2 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2004 | 75 | 0.060 |
Why?
|
| Calgranulin A | 1 | 2003 | 5 | 0.060 |
Why?
|
| Focal Adhesions | 1 | 2003 | 25 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2004 | 270 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 148 | 0.050 |
Why?
|
| Calcium | 2 | 2004 | 929 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 194 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2013 | 282 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 2223 | 0.050 |
Why?
|
| Bacterial Load | 2 | 2011 | 24 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 78 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2020 | 16 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2324 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2020 | 111 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 597 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 93 | 0.040 |
Why?
|
| Cecum | 1 | 2019 | 39 | 0.040 |
Why?
|
| Punctures | 1 | 2019 | 35 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 219 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 70 | 0.040 |
Why?
|
| Ligation | 1 | 2019 | 83 | 0.040 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 46 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 210 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 110 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 490 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 567 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 222 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 299 | 0.040 |
Why?
|
| Cell Division | 2 | 2003 | 541 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 341 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 332 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 371 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1664 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1056 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 1752 | 0.030 |
Why?
|
| Cadherin Related Proteins | 1 | 2015 | 9 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Body Patterning | 1 | 2015 | 44 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 159 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 90 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 100 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 866 | 0.030 |
Why?
|
| Zebrafish | 1 | 2015 | 187 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2015 | 166 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 13 | 2 | 2004 | 8 | 0.030 |
Why?
|
| Microbubbles | 1 | 2013 | 8 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 147 | 0.030 |
Why?
|
| Heterografts | 1 | 2013 | 70 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2004 | 305 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2012 | 13 | 0.030 |
Why?
|
| Adenoviridae | 2 | 2003 | 295 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 630 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 31 | 0.030 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1992 | 19 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 947 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2004 | 791 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 532 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1992 | 50 | 0.030 |
Why?
|
| Male | 3 | 2020 | 37321 | 0.030 |
Why?
|
| Tretinoin | 1 | 1992 | 92 | 0.020 |
Why?
|
| Calcitriol | 1 | 1992 | 106 | 0.020 |
Why?
|
| Nanoconjugates | 1 | 2011 | 2 | 0.020 |
Why?
|
| Isoindoles | 1 | 2011 | 9 | 0.020 |
Why?
|
| Nanocapsules | 1 | 2011 | 10 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 317 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 85 | 0.020 |
Why?
|
| Sonication | 1 | 2010 | 8 | 0.020 |
Why?
|
| Polyesters | 1 | 2011 | 55 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 45 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 2011 | 38 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 1047 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 144 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 53 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1083 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 306 | 0.020 |
Why?
|
| Herniorrhaphy | 1 | 2010 | 38 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 200 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1447 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 455 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 672 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 636 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 2083 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2004 | 3 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2004 | 12 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 92 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 107 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 168 | 0.010 |
Why?
|
| Tyrosine | 1 | 2004 | 196 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2003 | 24 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2003 | 39 | 0.010 |
Why?
|
| Paxillin | 1 | 2003 | 3 | 0.010 |
Why?
|
| G1 Phase | 1 | 2003 | 42 | 0.010 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Actinin | 1 | 2003 | 9 | 0.010 |
Why?
|
| Tetracycline | 1 | 2003 | 29 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 22 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2003 | 22 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 308 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 2003 | 16 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2003 | 30 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 51 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2005 | 122 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 247 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 105 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 194 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2003 | 105 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 130 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 237 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 233 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 108 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 322 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 246 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 175 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 742 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 258 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 489 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 202 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 1200 | 0.010 |
Why?
|
| Pyridines | 1 | 2003 | 261 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 615 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 597 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1027 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 981 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 1593 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1992 | 78 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1992 | 100 | 0.010 |
Why?
|